What is medCPU?
medCPU specializes in the in-depth review and benchmarking of contemporary laptops, tablets, and 2-in-1 devices. The company provides hands-on insights and practical tips designed to enhance user efficiency. Catering to a broad demographic including professionals, students, and gamers, medCPU offers personalized recommendations for a wide array of computing requirements. Leveraging over fifteen years of experience in tech blogging and a decade in healthcare technology solutions, medCPU is positioned to apply its technological expertise across diverse sectors. The platform facilitates comparisons and detailed reviews of prominent laptop brands and models, establishing it as a key resource in the consumer electronics review space.
How much funding has medCPU raised?
medCPU has raised a total of $48.6M across 4 funding rounds:
Series A
$1.3M
Series B
$9.3M
Debt
$3M
Other Financing Round
$35M
Series A (2011): $1.3M, investors not publicly disclosed
Series B (2014): $9.3M led by Easton Capital Partners and New Richmond Ventures
Debt (2015): $3M supported by Silicon Valley Bank
Other Financing Round (2016): $35M featuring UPMC and Merck Global Health Innovation Fund
Key Investors in medCPU
UPMC
UPMC is a major integrated health services provider and insurer, indicating a strategic interest in technology that can impact healthcare or operational efficiency.
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund is a venture capital arm focused on investing in companies that advance healthcare solutions, suggesting a focus on medCPU's potential in health-tech applications.
Easton Capital Partners
Easton Capital Partners is an investment group that provides growth capital for companies, indicating a belief in medCPU's scaling potential and market viability.
What's next for medCPU?
The recent major strategic investment in medCPU signals a pivotal growth phase, likely enabling the company to expand its product offerings, enhance its technological infrastructure, and broaden its market reach. This capital infusion is expected to fuel further innovation in device benchmarking and personalized tech recommendations, solidifying its position as a leader in consumer tech analysis and potentially exploring new verticals for its technology application.
See full medCPU company page
